Page 38 - GPD-2-3

Gene & Protein in Disease Signatures construction strategies for TC

73. Park J, Kim D, Lee JO, et al., 2022, Dissection of molecular https://doi.org/10.1016/j.amjms.2023.03.019
and histological subtypes of papillary thyroid cancer using 78. Chen H, Ma X, Yang M, 2020, A methylomics-associated
alternative splicing profiles. Exp Mol Med, 54(3): 263–272.
nomogram predicts recurrence-free survival of thyroid
https://doi.org/10.1038/s12276-022-00740-0 papillary carcinoma. Cancer Med, 9(19): 7183–7193.
74. Oltean S, Bates DO, 2014, Hallmarks of alternative splicing https://doi.org/10.1002/cam4.3388
in cancer. Oncogene, 33(46): 5311–5318.
79. Chen Z, Liu X, Liu F, et al., 2021, Identification of
https://doi.org/10.1038/onc.2013.533 4-methylation driven genes based prognostic signature
in thyroid cancer: An integrative analysis based on the
75. Abdullah MI, Junit SM, Ng KL, et al., 2019, Papillary thyroid
cancer: Genetic alterations and molecular biomarker methylmix algorithm. Aging (Albany NY), 13(16): 20164–
investigations. Int J Med Sci, 16(3): 450–460. 20178.
https://doi.org/10.18632/aging.203338
https://doi.org/10.7150/ijms.29935
80. Mou Y, Wang J, Wu J, et al., 2019, Ferroptosis, a new form of
76. Nikiforov YE, Nikiforova MN, 2011, Molecular genetics
and diagnosis of thyroid cancer. Nat Rev Endocrinol, 7(10): cell death: Opportunities and challenges in cancer. J Hematol
569–580. Oncol, 12(1): 34.
https://doi.org/10.1186/s13045-019-0720-y
https://doi.org/10.1038/nrendo.2011.142
81. Zhao H, De Souza C, Kumar VE, et al., 2021, Long non-
77. Zantut-Wittmann DE, Laus AC, Moreno DA, et al., 2023,
Extremely aggressive course in a poorly differentiated coding RNA signatures as predictors of prognosis in thyroid
thyroid carcinoma presenting a double mutation of the cancer: A narrative review. Ann Transl Med, 9(4): 359.
TERT promoter. Am J Med Sci, 365(6): 532–537. https://doi.org/10.21037/atm-20-8191

Volume 2 Issue 3 (2023) 22 https://doi.org/10.36922/gpd.1138